Cargando…

In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy

We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruppé, E., Cherkaoui, A., Wagner, N., La Scala, G.C., Beaulieu, J.-Y., Girard, M., Frey, J., Lazarevic, V., Schrenzel, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709350/
https://www.ncbi.nlm.nih.gov/pubmed/29204282
http://dx.doi.org/10.1016/j.nmni.2017.10.005
_version_ 1783282756133847040
author Ruppé, E.
Cherkaoui, A.
Wagner, N.
La Scala, G.C.
Beaulieu, J.-Y.
Girard, M.
Frey, J.
Lazarevic, V.
Schrenzel, J.
author_facet Ruppé, E.
Cherkaoui, A.
Wagner, N.
La Scala, G.C.
Beaulieu, J.-Y.
Girard, M.
Frey, J.
Lazarevic, V.
Schrenzel, J.
author_sort Ruppé, E.
collection PubMed
description We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain indeed revealed 13 antibiotic resistance genes, including the ESBL CTX-M-3 and the unusual β-lactamase SCO-1.
format Online
Article
Text
id pubmed-5709350
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57093502017-12-04 In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy Ruppé, E. Cherkaoui, A. Wagner, N. La Scala, G.C. Beaulieu, J.-Y. Girard, M. Frey, J. Lazarevic, V. Schrenzel, J. New Microbes New Infect New Resistant Microbes in Human We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain indeed revealed 13 antibiotic resistance genes, including the ESBL CTX-M-3 and the unusual β-lactamase SCO-1. Elsevier 2017-10-10 /pmc/articles/PMC5709350/ /pubmed/29204282 http://dx.doi.org/10.1016/j.nmni.2017.10.005 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle New Resistant Microbes in Human
Ruppé, E.
Cherkaoui, A.
Wagner, N.
La Scala, G.C.
Beaulieu, J.-Y.
Girard, M.
Frey, J.
Lazarevic, V.
Schrenzel, J.
In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title_full In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title_fullStr In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title_full_unstemmed In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title_short In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
title_sort in vivo selection of a multidrug-resistant aeromonas salmonicida during medicinal leech therapy
topic New Resistant Microbes in Human
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709350/
https://www.ncbi.nlm.nih.gov/pubmed/29204282
http://dx.doi.org/10.1016/j.nmni.2017.10.005
work_keys_str_mv AT ruppee invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT cherkaouia invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT wagnern invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT lascalagc invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT beaulieujy invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT girardm invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT freyj invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT lazarevicv invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy
AT schrenzelj invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy